CN102285914B - Synthesis method of 2-(1-methyl-6-carboxy-1,6-dihydropyridine)-acetic acid - Google Patents

Synthesis method of 2-(1-methyl-6-carboxy-1,6-dihydropyridine)-acetic acid Download PDF

Info

Publication number
CN102285914B
CN102285914B CN 201010205020 CN201010205020A CN102285914B CN 102285914 B CN102285914 B CN 102285914B CN 201010205020 CN201010205020 CN 201010205020 CN 201010205020 A CN201010205020 A CN 201010205020A CN 102285914 B CN102285914 B CN 102285914B
Authority
CN
China
Prior art keywords
methyl
pyridine
acetic acid
dihydro
carbonyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN 201010205020
Other languages
Chinese (zh)
Other versions
CN102285914A (en
Inventor
肖贻崧
符爽
廖江鹏
柏祝
贺海鹰
陈曙辉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai SynTheAll Pharmaceutical Co Ltd
Original Assignee
Wuxi Apptec Co Ltd
Wuxi Apptec Tianjin Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wuxi Apptec Co Ltd, Wuxi Apptec Tianjin Co Ltd filed Critical Wuxi Apptec Co Ltd
Priority to CN 201010205020 priority Critical patent/CN102285914B/en
Publication of CN102285914A publication Critical patent/CN102285914A/en
Application granted granted Critical
Publication of CN102285914B publication Critical patent/CN102285914B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Pyridine Compounds (AREA)

Abstract

The invention relates to a synthesis method of 2-(1-methyl-6-carboxy-1,6-dihydropyridine)-acetic acid, wherein problems that the current synthesis route is lacked, the reaction route is long, the post-treatment is complex, the amplification is difficult, the applicability is not wide and the like are solved by a fast efficient acetic acid group introducing method mainly. The synthesis method comprises the following steps of: reacting 6- chloro-1-hydrogen-pyridine-2-ketone 1 with a methylating reagent in the presence of an alkalization reagent to obtain 1-methyl-6-chloro-1-hydrogen-pyridine-2-ketone 2; reacting the compound 2 with acetonitrile in a solvent in the presence of the alkalization reagent, n-butyl lithium, at low temperature to generate 2-(1- methyl-6-carboxy-1,6-dihydropyridine)-acetonitrile 3; and hydrolyzing the compound 3 under the acidic condition to obtain the final product, 2-(1- methyl-6-carboxy-1,6-dihydropyridine)-acetic acid 4. A large amount of 2-(1- methyl-6-carboxy-1,6-dihydropyridine)-acetic acid can be quickly and conveniently prepared through the synthesis route disclosed by the invention.

Description

The synthetic method of 2-(1-methyl-6-carbonyl-1,6-dihydro-pyridine)-acetic acid
Technical field
The present invention relates to the synthetic method of a kind of important medicine intermediate 2-(1-methyl-6-carbonyl-1,6-dihydro-pyridine)-acetic acid.
Background technology
2-(1-methyl-6-carbonyl-1,6-dihydro-pyridine)-acetic acid is a kind of important medicine intermediate, owing to having hydrogen bond donor and hydrogen bond receptor on its molecule simultaneously, can be widely used in the design of drug molecule; Its carboxyl, can synthesize from other a lot of drug template molecular reactions the drug molecule of various different demands.6-carbonyl-1, the derivative of 6-dihydro-pyridine-formic acid has more bibliographical information, and US20050245530 and US20070259862 have reported that respectively this compounds has certain anticancer and anti-gastroesophageal reflux effect.Therefore 2-(1-methyl-6-carbonyl-1,6-dihydro-pyridine)-acetic acid has wide Research Prospects.But the synthetic report for this intermediate is few, the synthetic route of 2-(1-methyl-6-carbonyl-1,6-dihydro-pyridine)-acetic acid of having only had at present one piece of bibliographical information, but these synthetic routes are very long, raw material costliness, and aftertreatment complexity, be difficult to the synthetic of the scale of being amplified.
Summary of the invention
The object of the present invention is to provide a kind of 2-(1-methyl-6-carbonyl-1, the new synthetic method of 6-dihydro-pyridine)-acetic acid, the reaction scheme that mainly by a kind of method of rapidly and efficiently introducing aceticoceptor, solves existing synthetic route shortage and exist is long, the technical problems such as aftertreatment is complicated, the amplification difficulty, and suitability is wideless.
The synthetic method of technical scheme of the present invention: 2-(1-methyl-6-carbonyl-1,6-dihydro-pyridine)-acetic acid comprises the following steps:
It is raw material that the chloro-1-hydrogen-pyridin-2-ones of 6-is take in the first step reaction, with methylating reagent, under alkalizing agent exists, reacts and obtains the chloro-1-hydrogen-pyridin-2-ones of 1-methyl-6-;
The second step reaction under the chloro-1-hydrogen of 1-methyl-6--pyridin-2-ones cold condition, in solvent, generates 2-(1-methyl-6-carbonyl-1,6-dihydro-pyridine)-acetonitrile with acetonitrile reaction under the alkalizing agent n-Butyl Lithium exists;
Three-step reaction, 2-(1-methyl-6-carbonyl-1,6-dihydro-pyridine)-acetonitrile is hydrolyzed and obtains 2-(1-methyl-6-carbonyl-1,6-dihydro-pyridine)-acetic acid under acidic conditions;
Chemical equation is as follows:
The first step reaction is carried out in solvent, and solvent is a kind of in methyl alcohol, ethanol or DMF; Alkalizing agent is salt of wormwood or cesium carbonate, and its consumption molar weight is 2.0 equivalents; A kind of with in methyl iodide or methyl-sulfate of methylating reagent; ; Temperature of reaction is 0~80 ℃; Reaction times is 3~18 hours.
The second step reaction, solvent is anhydrous tetrahydro furan or dry toluene; Described cold condition is: temperature of reaction is-40~-78 ℃; Reaction times is 3~4 hours.
Acid in three-step reaction is concentrated hydrochloric acid (the quality percentage composition is 38%) or the vitriol oil (the quality percentage composition is for being more than or equal to 50%); Temperature of reaction is 100~150 ℃, preferably 100~130 ℃; Reaction times is 2~6 hours.
The invention has the beneficial effects as follows: the invention provides a kind of synthetic route of novelty, can be from starting compound cheap, that be easy to get 1prepare quickly and easily a kind of important medicine intermediate 2-(1-methyl-6-carbonyl-1,6-dihydro-pyridine)-acetic acid.This technique is three-step reaction altogether, and total recovery can reach 60%.
Embodiment
Following instance contributes to understand content of the present invention, the present invention includes but be not limited to following related content:
1.1-the chloro-1-hydrogen-pyridin-2-ones of methyl-6- 2synthetic
embodiment 1
By the chloro-1-hydrogen-pyridin-2-ones of 6- 1(60 g, 0.46 mol), salt of wormwood (128 g, 0.92 mol), methyl iodide (130 g, 0.92 mol) join respectively in ethanol (800 mL), this mixture is warming up to 50 ℃, react and after 16 hours, the solvent in system is spin-dried for, add 1L water in the solid mixture after being spin-dried for, with dichloromethane extraction (500 mL*2), merge organic phase and use again the saturated common salt water washing, anhydrous sodium sulfate drying, remove by filter siccative after concentrated filtrate obtain the chloro-1-hydrogen-pyridin-2-ones of 1-methyl-6- 2(55g, 82.6%).
[0018] proton nmr spectra (DMSO, 400 MHz), δppm:7.18-7.22 (m, 1H), 6.45-6.48 (m, 1H), 6.26-6.28 (m, 1H), 3.65 (s, 3H).
embodiment 2
By the chloro-1-hydrogen-pyridin-2-ones of 6- 1(60 g, 0.46 mol), cesium carbonate (300 g, 0.92 mol), methyl iodide (130 g, 0.92 mol) add respectively in methyl alcohol (800 mL), this mixture is spin-dried for the solvent in system after 16 hours in the lower reaction of room temperature (20~30 ℃), add 1L water in the solid mixture after being spin-dried for, with dichloromethane extraction (500 mL*2), merge organic phase and use again the saturated common salt water washing, anhydrous sodium sulfate drying, remove by filter siccative after concentrated filtrate obtain the chloro-1-hydrogen-pyridin-2-ones of 1-methyl-6- 2(45 g, 69.2%).
embodiment 3
By the chloro-1-hydrogen-pyridin-2-ones of 6- 1(60 g, 0.46 mol), salt of wormwood (128 g, 0.92 mol), methyl-sulfate (86 g, 0.92 mol) add respectively N, in dinethylformamide (800 mL), this mixture is warmed up to 80 ℃, reacts after 4 hours the solvent in system is spin-dried for, in the solid mixture after being spin-dried for, add 1L water, with dichloromethane extraction (500 mL*2), merge organic phase and use again the saturated common salt water washing, anhydrous sodium sulfate drying, remove by filter siccative after concentrated filtrate obtain the chloro-1-hydrogen-pyridin-2-ones of 1-methyl-6- 2(35 g, 53.8%).
(2.2-1-methyl-6-carbonyl-1,6-dihydro-pyridine)-acetonitrile
embodiment 4
Add n-Butyl Lithium (480 mL in the 1.5L anhydrous tetrahydro furan under-78 ℃, 1.2 mol), slowly splash into again acetonitrile (49.2 g, 1.2 mol), in whole dropping process, temperature is controlled at-40~-78 ℃, stir adularescent solid after 45 minutes and produce, by the chloro-1-hydrogen-pyridin-2-ones of 1-methyl-6- 2the tetrahydrofuran solution of (55 g, 0.38 mol) splashes into above-mentioned white reaction system at-40~-78 ℃, stirs after two hours and slowly is raised to room temperature, continues to stir reaction system after 30 minutes and becomes sorrel, adds the 1L frozen water will react cancellation.By the 1L ethyl acetate, the ester solubility impurity in reaction system is washed away to concentrated 2-(1-methyl-6-carbonyl-1,6-dihydro-pyridine)-acetonitrile that obtains of rear water 3(50 g, 89%).
embodiment 5
Add n-Butyl Lithium (480 mL in the 1.5L dry toluene under-78 ℃, 1.2 mol), slowly splash into again acetonitrile (49.2 g, 1.2 mol), in whole dropping process, temperature is controlled at-40~-78 ℃, stir adularescent solid after 45 minutes and produce, by the chloro-1-hydrogen-pyridin-2-ones of 1-methyl-6- 2the tetrahydrofuran solution of (55 g, 0.38 mol) splashes into above-mentioned white reaction system at-40~-78 ℃, stirs after two hours and slowly is raised to room temperature, continues to stir reaction system after 30 minutes and becomes sorrel, adds the 1L frozen water will react cancellation.By the 1L ethyl acetate, the ester solubility impurity in reaction system is washed away to concentrated 2-(1-methyl-6-carbonyl-1,6-dihydro-pyridine)-acetonitrile that obtains of rear water 3(35 g, 62%).
[0028](3.2-1-methyl-6-carbonyl-1,6-dihydro-pyridine)-acetic acid 4synthetic
embodiment 6
By 2-(1-methyl-6-carbonyl-1,6-dihydro-pyridine)-acetonitrile 3(50 g) adds in 1L water, add again 500 mL concentrated hydrochloric acids, stir 2~6 hours after being heated to 100~130 ℃, reaction solution is concentrated except anhydrating and hydrogen chloride gas obtains thick product, obtain 2-(1-methyl-6-carbonyl-1,6-dihydro-pyridine)-acetic acid by re-crystallizing in ethyl acetate 4(48 g, 86%).Proton nmr spectra (DMSO, 400 MHz), δppm:7.32-7.36 (dd, j1=8.8 Hz, j2=6.8 Hz, 1H), 6.35 (d, j=8.8 Hz, 1H), 6.22 (d, j=6.4 Hz, 1H), 3.82 (s, 2H), 3.40 (s, 3H).
embodiment 7
By 2-(1-methyl-6-carbonyl-1,6-dihydro-pyridine)-acetonitrile 3(50 g) adds in 1L water, add again in 500 mL 50% vitriol oils, stir 2~6 hours after being heated to 100~130 ℃, obtain thick product except anhydrating by reaction solution is concentrated, obtain 2-(1-methyl-6-carbonyl-1,6-dihydro-pyridine)-acetic acid by re-crystallizing in ethyl acetate 4(41.0 g, 73%).

Claims (5)

1.2-the synthetic method of (1-methyl-6-carbonyl-1,6-dihydro-pyridine)-acetic acid comprises the following steps:
It is raw material that the chloro-1-hydrogen-pyridin-2-ones of 6-is take in the first step reaction, with methylating reagent, under alkalizing agent exists, reacts and obtains the chloro-1-hydrogen-pyridin-2-ones of 1-methyl-6-;
The second step reaction under the chloro-1-hydrogen of 1-methyl-6--pyridin-2-ones cold condition, in solvent, generates 2-(1-methyl-6-carbonyl-1,6-dihydro-pyridine)-acetonitrile with acetonitrile reaction under the alkalizing agent n-Butyl Lithium exists;
Three-step reaction, 2-(1-methyl-6-carbonyl-1,6-dihydro-pyridine)-acetonitrile is hydrolyzed and obtains 2-(1-methyl-6-carbonyl-1,6-dihydro-pyridine)-acetic acid under acidic conditions.
2. the synthetic method of 2-according to claim 1 (1-methyl-6-carbonyl-1,6-dihydro-pyridine)-acetic acid, is characterized in that, the first step reaction is carried out in solvent, and solvent is a kind of in methyl alcohol, ethanol or DMF; Alkalizing agent is salt of wormwood or cesium carbonate, methyl iodide or methyl-sulfate for methylating reagent; Temperature of reaction is 0~80 ℃; Reaction times is 3~18 hours.
3. the synthetic method of 2-according to claim 2 (1-methyl-6-carbonyl-1,6-dihydro-pyridine)-acetic acid, is characterized in that, the alkalizing agent consumption is 2.0 equivalents.
4. the synthetic method of 2-according to claim 1 (1-methyl-6-carbonyl-1,6-dihydro-pyridine)-acetic acid, is characterized in that, the second step reaction, and solvent is anhydrous tetrahydro furan or dry toluene; Described cold condition is: temperature of reaction is-40~-78 ℃; Reaction times is 3~4 hours.
5. the synthetic method of 2-according to claim 1 (1-methyl-6-carbonyl-1,6-dihydro-pyridine)-acetic acid, is characterized in that, the acid in three-step reaction is concentrated hydrochloric acid or the vitriol oil; Temperature of reaction is 100~130 ℃; Reaction times is 2~6 hours.
CN 201010205020 2010-06-18 2010-06-18 Synthesis method of 2-(1-methyl-6-carboxy-1,6-dihydropyridine)-acetic acid Active CN102285914B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201010205020 CN102285914B (en) 2010-06-18 2010-06-18 Synthesis method of 2-(1-methyl-6-carboxy-1,6-dihydropyridine)-acetic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201010205020 CN102285914B (en) 2010-06-18 2010-06-18 Synthesis method of 2-(1-methyl-6-carboxy-1,6-dihydropyridine)-acetic acid

Publications (2)

Publication Number Publication Date
CN102285914A CN102285914A (en) 2011-12-21
CN102285914B true CN102285914B (en) 2013-12-25

Family

ID=45332693

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201010205020 Active CN102285914B (en) 2010-06-18 2010-06-18 Synthesis method of 2-(1-methyl-6-carboxy-1,6-dihydropyridine)-acetic acid

Country Status (1)

Country Link
CN (1) CN102285914B (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4496542A (en) * 1981-03-30 1985-01-29 Usv Pharmaceutical Corporation N-substituted-amido-amino acids
CN101128199A (en) * 2004-04-23 2008-02-20 布里斯托尔-迈尔斯斯奎布公司 Monocyclic heterocycles as kinase inhibitors
CN101506202A (en) * 2006-05-05 2009-08-12 阿斯利康(瑞典)有限公司 mGluR5 modulators I

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4496542A (en) * 1981-03-30 1985-01-29 Usv Pharmaceutical Corporation N-substituted-amido-amino acids
CN101128199A (en) * 2004-04-23 2008-02-20 布里斯托尔-迈尔斯斯奎布公司 Monocyclic heterocycles as kinase inhibitors
CN101506202A (en) * 2006-05-05 2009-08-12 阿斯利康(瑞典)有限公司 mGluR5 modulators I

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
"Organometallic Enantiomeric Scaffolding: General Access to 2-Substituted Oxa- and Azabicyclo[3.2.1]octenes via a Brosnted Acid Catalyzed [5+2] Cycloaddition Reaction";Ethel C. Garnier et al.;《Journal of American Chemical Society》;20080515;第130卷(第23期);第7449-7458页 *
"Synthesis and Biological Activity of Substituted [ [3(S)-(Acylamino)-2-oxo-l-azetidinyl]oxy]acetic Acids. A New Class of Heteroatom-Activated B-Lactam Antibiotics";Steven R. Woulfe et al.;《Journal of Medicinal Chemistry》;19851231;第28卷(第10期);第1447-1453页 *
Ethel C. Garnier et al.."Organometallic Enantiomeric Scaffolding: General Access to 2-Substituted Oxa- and Azabicyclo[3.2.1]octenes via a Brosnted Acid Catalyzed [5+2] Cycloaddition Reaction".《Journal of American Chemical Society》.2008,第130卷(第23期),第7449-7458页.
Steven R. Woulfe et al.."Synthesis and Biological Activity of Substituted [ [3(S)-(Acylamino)-2-oxo-l-azetidinyl]oxy]acetic Acids. A New Class of Heteroatom-Activated B-Lactam Antibiotics".《Journal of Medicinal Chemistry》.1985,第28卷(第10期),第1447-1453页.

Also Published As

Publication number Publication date
CN102285914A (en) 2011-12-21

Similar Documents

Publication Publication Date Title
CN104876995A (en) A preparing method of a chenodeoxycholic acid derivative
JP2019500322A (en) Compound having agonistic effect on GPR84, method for producing the same, and use
CN103130719B (en) A kind of polysubstituted imidazoles Calixarene Derivatives and preparation method
CN102617587A (en) Synthesis method for 2,3,6,7-triptycene tetracarboxylic dianhydride
CN103204801A (en) Synthesis method for N-Boc-3-piperidone
CN102603843B (en) Preparation method of dexamethasone intermediate
CN101973932B (en) Preparation method of bisacodyl
CN103254265A (en) Abiraterone acetate trifluoroacetate, and preparation method and application thereof
CN104387392A (en) Method for preparing tofacitinib
CN104193638A (en) Method for preparing (S)-2',6'-dimethyl tyrosine and derivative of (S)-2',6'-dimethyl tyrosine, and derivative
CN102285914B (en) Synthesis method of 2-(1-methyl-6-carboxy-1,6-dihydropyridine)-acetic acid
CN102030707A (en) Method for preparing Blonanserin intermediate
CN103880745A (en) Chemical synthesis method of 6-bromo-1,2,3,4-tetrahydroisoquinolyl-1-formic acid
CN103923040B (en) A kind of method preparing furfural oxime acid
CN102070533A (en) New method for synthesizing 4-(1-hydroxyl-1-methyl ethyl)-2-propyl imidazole-5-carboxylic acid ethyl ester
CN102372707B (en) The synthetic method of 6-methyl-4-bromo-1,6-pyrrolin [2,3-c] pyridin-7-one
CN103351346A (en) Preparation method of impurity HP1 in bendamustine hydrochloride
CN103539728A (en) Synthesis method of lansoprazole drug intermediate chloromethyl pyridine derivative
CN114805120A (en) Synthesis process of m-cyanomethyl benzoate
RU2709493C1 (en) Method of producing roxadustat
CN111116493B (en) Method for preparing Apabetalone, intermediate and preparation method of intermediate
CN103980139B (en) Sunaptic acid compounds and preparation method thereof
CN108129430A (en) A kind of synthetic method of Li Tasite intermediates
CN102093247B (en) Preparation method of 2-methyl-4-N-(2-methylbenzoyl)benzoic acid
CN102690211B (en) The preparation method of tolvaptan intermediate

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20170209

Address after: Jinshan District of Shanghai chemical industrial zone of Shanghai city Jinshan District 201507 (West) Yuegong Road No. 9

Patentee after: Shanghai SynTheAll Pharmaceutical Co., Ltd.

Address before: 200131 Shanghai City, Pudong New Area Waigaoqiao Free Trade Zone Foote Road No. 288

Patentee before: Shanghai Yaoming Kangde New Medicine Development Co., Ltd.

Patentee before: Tianjin Yaoming Kangde New Medicine Development Co., Ltd.

TR01 Transfer of patent right